TY - JOUR
T1 - Precarious connections
T2 - Making therapeutic production happen for malaria and tuberculosis
AU - Craddock, Susan
N1 - Publisher Copyright:
© 2014 Elsevier Ltd.
PY - 2015/3/1
Y1 - 2015/3/1
N2 - The One Health Movement has been a primary advocate for collaboration across disciplinary and organizational sectors in the study of infectious diseases. There is potentially much to be gained by incorporating the interrelations of animal and human ecosystems, as well as the expertise of veterinary, medical, and public health practitioners. Too often, however, the idea rather than the realities of collaboration become valorized within One Health approaches. Paying little to no attention to the motivations, ontologies, and politics of collaborative arrangements, however, is a critical mistake, one that diminishes considerably One Health framework explanatory powers. Using Anna Tsing's framework of friction, in this paper I take the examples of malaria and tuberculosis pharmaceuticals collaborations, often called Product Development Partnerships, to argue for the need to attend to the conditions under which collaborations across divergent disciplines, geographies, organizations, and institutions might work productively and when they do not.
AB - The One Health Movement has been a primary advocate for collaboration across disciplinary and organizational sectors in the study of infectious diseases. There is potentially much to be gained by incorporating the interrelations of animal and human ecosystems, as well as the expertise of veterinary, medical, and public health practitioners. Too often, however, the idea rather than the realities of collaboration become valorized within One Health approaches. Paying little to no attention to the motivations, ontologies, and politics of collaborative arrangements, however, is a critical mistake, one that diminishes considerably One Health framework explanatory powers. Using Anna Tsing's framework of friction, in this paper I take the examples of malaria and tuberculosis pharmaceuticals collaborations, often called Product Development Partnerships, to argue for the need to attend to the conditions under which collaborations across divergent disciplines, geographies, organizations, and institutions might work productively and when they do not.
KW - Collaborations
KW - Malaria
KW - One health
KW - Tuberculosis
UR - http://www.scopus.com/inward/record.url?scp=84923375874&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84923375874&partnerID=8YFLogxK
U2 - 10.1016/j.socscimed.2014.07.039
DO - 10.1016/j.socscimed.2014.07.039
M3 - Article
C2 - 25142906
AN - SCOPUS:84923375874
SN - 0277-9536
VL - 129
SP - 36
EP - 43
JO - Social Science and Medicine
JF - Social Science and Medicine
ER -